174 related articles for article (PubMed ID: 17445136)
1. Risk factors for treatment denial and loss to follow-up in an antiretroviral treatment cohort in Kenya.
Karcher H; Omondi A; Odera J; Kunz A; Harms G
Trop Med Int Health; 2007 May; 12(5):687-94. PubMed ID: 17445136
[TBL] [Abstract][Full Text] [Related]
2. Payment for antiretroviral drugs is associated with a higher rate of patients lost to follow-up than those offered free-of-charge therapy in Nairobi, Kenya.
Zachariah R; Van Engelgem I; Massaquoi M; Kocholla L; Manzi M; Suleh A; Phillips M; Borgdorff M
Trans R Soc Trop Med Hyg; 2008 Mar; 102(3):288-93. PubMed ID: 18258272
[TBL] [Abstract][Full Text] [Related]
3. The effect of depressive symptoms at ART initiation on HIV clinical progression and mortality: implications in clinical practice.
Villes V; Spire B; Lewden C; Perronne C; Besnier JM; Garré M; Chêne G; Leport C; Carrieri MP; Le Moings V;
Antivir Ther; 2007; 12(7):1067-74. PubMed ID: 18018765
[TBL] [Abstract][Full Text] [Related]
4. CD4+ guided antiretroviral treatment interruption in HIV infection: a meta-analysis.
Seminari E; De Silvestri A; Boschi A; Tinelli C
AIDS Rev; 2008; 10(4):236-44. PubMed ID: 19092979
[TBL] [Abstract][Full Text] [Related]
5. Increased mortality of male adults with AIDS related to poor compliance to antiretroviral therapy in Malawi.
Chen SC; Yu JK; Harries AD; Bong CN; Kolola-Dzimadzi R; Tok TS; King CC; Wang JD
Trop Med Int Health; 2008 Apr; 13(4):513-9. PubMed ID: 18282238
[TBL] [Abstract][Full Text] [Related]
6. Risk of cancers during interrupted antiretroviral therapy in the SMART study.
Silverberg MJ; Neuhaus J; Bower M; Gey D; Hatzakis A; Henry K; Hidalgo J; Lourtau L; Neaton JD; Tambussi G; Abrams DI
AIDS; 2007 Sep; 21(14):1957-63. PubMed ID: 17721103
[TBL] [Abstract][Full Text] [Related]
7. Five-year experience with scaling-up access to antiretroviral treatment in an HIV care programme in Cambodia.
Thai S; Koole O; Un P; Ros S; De Munter P; Van Damme W; Jacques G; Colebunders R; Lynen L
Trop Med Int Health; 2009 Sep; 14(9):1048-58. PubMed ID: 19573140
[TBL] [Abstract][Full Text] [Related]
8. Adverse events to antiretrovirals in the Swiss HIV Cohort Study: effect on mortality and treatment modification.
Keiser O; Fellay J; Opravil M; Hirsch HH; Hirschel B; Bernasconi E; Vernazza PL; Rickenbach M; Telenti A; Furrer H;
Antivir Ther; 2007; 12(8):1157-64. PubMed ID: 18240856
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of antiretroviral treatment in a South African program: a cohort study.
Fairall LR; Bachmann MO; Louwagie GM; van Vuuren C; Chikobvu P; Steyn D; Staniland GH; Timmerman V; Msimanga M; Seebregts CJ; Boulle A; Nhiwatiwa R; Bateman ED; Zwarenstein MF; Chapman RD
Arch Intern Med; 2008 Jan; 168(1):86-93. PubMed ID: 18195200
[TBL] [Abstract][Full Text] [Related]
10. Detection of HIV drug resistance during antiretroviral treatment and clinical progression in a large European cohort study.
Cozzi-Lepri A; Phillips AN; Clotet B; Mocroft A; Ruiz L; Kirk O; Lazzarin A; Wiercinska-Drapalo A; Karlsson A; Lundgren JD;
AIDS; 2008 Oct; 22(16):2187-98. PubMed ID: 18832882
[TBL] [Abstract][Full Text] [Related]
11. Determinants of mortality and nondeath losses from an antiretroviral treatment service in South Africa: implications for program evaluation.
Lawn SD; Myer L; Harling G; Orrell C; Bekker LG; Wood R
Clin Infect Dis; 2006 Sep; 43(6):770-6. PubMed ID: 16912954
[TBL] [Abstract][Full Text] [Related]
12. Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-score.
Mocroft A; Ledergerber B; Zilmer K; Kirk O; Hirschel B; Viard JP; Reiss P; Francioli P; Lazzarin A; Machala L; Phillips AN; Lundgren JD;
AIDS; 2007 Sep; 21(14):1867-75. PubMed ID: 17721094
[TBL] [Abstract][Full Text] [Related]
13. Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patients.
Soria A; Porten K; Fampou-Toundji JC; Galli L; Mougnutou R; Buard V; Kfutwah A; Vessière A; Rousset D; Teck R; Calmy A; Ciaffi L; Lazzarin A; Gianotti N
Antivir Ther; 2009; 14(3):339-47. PubMed ID: 19474468
[TBL] [Abstract][Full Text] [Related]
14. Antiretroviral therapy in AIDS patients with CMV disease: impact on the survival and long-term treatment outcome.
Sungkanuparph S; Chakriyanuyok T; Butthum B
J Infect; 2008 Jan; 56(1):40-3. PubMed ID: 18037166
[TBL] [Abstract][Full Text] [Related]
15. HIV-infected pregnant women have greater adherence with antiretroviral drugs than non-pregnant women.
Vaz MJ; Barros SM; Palacios R; Senise JF; Lunardi L; Amed AM; Castelo A
Int J STD AIDS; 2007 Jan; 18(1):28-32. PubMed ID: 17326859
[TBL] [Abstract][Full Text] [Related]
16. Incidence rate and risk factors for loss to follow-up in a French clinical cohort of HIV-infected patients from January 1985 to January 1998.
Lebouché B; Yazdanpanah Y; Gérard Y; Sissoko D; Ajana F; Alcaraz I; Boitte P; Cadoré B; Mouton Y
HIV Med; 2006 Apr; 7(3):140-5. PubMed ID: 16494627
[TBL] [Abstract][Full Text] [Related]
17. Differences in normal activities, job performance and symptom prevalence between patients not yet on antiretroviral therapy and patients initiating therapy in South Africa.
Rosen S; Ketlhapile M; Sanne I; Desilva MB
AIDS; 2008 Jul; 22 Suppl 1():S131-9. PubMed ID: 18664945
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for excess mortality and death in adults with tuberculosis in Western Kenya.
van't Hoog AH; Williamson J; Sewe M; Mboya P; Odeny LO; Agaya JA; Amolloh M; Borgdorff MW; Laserson KF
Int J Tuberc Lung Dis; 2012 Dec; 16(12):1649-56. PubMed ID: 23131264
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for high early mortality in patients on antiretroviral treatment in a rural district of Malawi.
Zachariah R; Fitzgerald M; Massaquoi M; Pasulani O; Arnould L; Makombe S; Harries AD
AIDS; 2006 Nov; 20(18):2355-60. PubMed ID: 17117022
[TBL] [Abstract][Full Text] [Related]
20. Is the interruption of antiretroviral treatment during pregnancy an additional major risk factor for mother-to-child transmission of HIV type 1?
Galli L; Puliti D; Chiappini E; Gabiano C; Ferraris G; Mignone F; Viganò A; Giaquinto C; Genovese O; Anzidei G; Badolato R; Buffolano W; Maccabruni A; Salvini F; Cellini M; Ruggeri M; Manzionna M; Bernardi S; Tovo P; de Martino M;
Clin Infect Dis; 2009 May; 48(9):1310-7. PubMed ID: 19309307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
